The discipline of medical imaging known as molecular imaging focuses on visualising molecules of medical importance within living patients. This is in contrast to histology, which is a common approach for extracting molecular information from preserved tissue samples. The molecules of interest might be natural molecules generated by the body or synthetic molecules created in a lab and injected into a patient by a doctor. Injecting a contrast agent into a patient's circulation and using an imaging modality to follow its travel in the body is the most typical example of molecular imaging utilised in clinical practise today. The science of radiology developed molecular imaging to better comprehend fundamental molecular processes inside organisms in a noninvasive manner.
The demand for efficient and reliable imaging systems will increase as the prevalence of cancer and other chronic diseases rises as a result of unhealthy lifestyles and an often growing senior population. The progress of technologies like as PET/CT and SPECT, as well as other factors, is the primary growth driver of the molecular imaging industry. Furthermore, the increased acceptance of molecular imaging in emerging economies such as China, India, and others would open new doors for the Molecular Imaging Market.
The number of molecular imaging applications has grown as technology has progressed. Molecular imaging has emerged as a potential method for early diagnosis of malignancies and heart disorders, as well as tracking tumour formation throughout sickness. Molecular imaging allows doctors to reliably analyse individual patients' biological reactions to therapy over time, paving the way for customised medicine tactics driven by molecular imaging reporters.
Read more @ https://cmiaspireblog.blogspot.com/2021/12/molecular-imaging-market-size-share.html
